SLC22A4 and Hepatic fibrosis: Supplementation with ET decreased oxidative damage and DMN-induced activation of liver fibrosis, while conversely, knocking out OCTN1 resulted in a significant elevation of liver fibrosis markers, oxidative damage, and inflammation in mice [55].